Promoting Early Adolescent Non-smoking With a Game Intervention Supporting Self-efficacy

Sponsor
University of Turku (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05290103
Collaborator
(none)
750
1
2
2.9
256.5

Study Details

Study Description

Brief Summary

This intervention study evaluates the effectiveness of a digital game intervention supporting smoking refusal self-efficacy among early adolescents (10-13 y). The participants are randomly allocated to two groups: the experimental group that receives the digital game intervention, and the control group that receives no intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Game intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
750 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Promoting Early Adolescent Non-smoking With a Game Intervention Supporting Self-efficacy
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
May 1, 2022
Anticipated Study Completion Date :
May 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Game intervention

Participants in this arm will receive the game intervention including 15-30 minutes of digital health game playing at school and 2 weeks of free usage of the game during free time and a 30-minute debriefing session with a researcher.

Behavioral: Game intervention
Game intervention consists of 15-30 minutes digital health game playing at school and 2 weeks free usage of the digital health game during free time. In addition, after the 2 weeks period of game playing, 30-minute debriefing sessions with a research are held. The digital health game includes visualized elements with sound effects that aim at increasing understanding about the consequences of tobacco product use and supporting refusal skills. The health game includes different mini-games and also textual information. The debriefing sessions with a researcher include small group and group discussions about the themes presented in the game. A researcher leads and teachers facilitate the discussions. The debriefing sessions aim to connect the game experience with daily life situations.

No Intervention: No intervention

The participants in this arm will receive no intervention.

Outcome Measures

Primary Outcome Measures

  1. Change in smoking refusal self-efficacy [At baseline, at 2 weeks, and at 3 months]

    Assessed with a smoking refusal self-efficacy scale (scores 6-24; higher scores indicate stronger smoking refusal self-efficacy).

Secondary Outcome Measures

  1. Change in sources of refusal self-efficacy related to tobacco use [At baseline, at 2 weeks, and at 3 months]

    Subscales for cigarette use (7 items) and snus use (7 items). Both are assessed with a 4-point Likert-scale questionnaire.

  2. Change in motivation to decline tobacco use in the future [At baseline, at 2 weeks, and at 3 months]

    Subscales for cigarette use and snus use. Both are assessed with a 4-point Likert-scale questionnaire (scores 1-4, lower scores indicate stonger motivation to decline tobacco use in future).

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 13 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Goes to school at 4th, 5th, or 6th grade

  • Sufficient skills in Finnish or Swedish

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Primary schools (n=15) Nine Cities Finland

Sponsors and Collaborators

  • University of Turku

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Johanna Nyman, Doctoral candidate, University of Turku
ClinicalTrials.gov Identifier:
NCT05290103
Other Study ID Numbers:
  • PEANS2022
First Posted:
Mar 22, 2022
Last Update Posted:
Mar 22, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 22, 2022